Cargando…

Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States

BACKGROUND: The COVID-19 pandemic has led to delays in patients seeking care for life-threatening conditions; however, its impact on treatment patterns for patients with metastatic cancer is unknown. We assessed the COVID-19 pandemic’s impact on time to treatment initiation (TTI) and treatment selec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parikh, Ravi B, Takvorian, Samuel U, Vader, Daniel, Paul Wileyto, E, Clark, Amy S, Lee, Daniel J, Goyal, Gaurav, Rocque, Gabrielle B, Dotan, Efrat, Geynisman, Daniel M, Phull, Pooja, Spiess, Philippe E, Kim, Roger Y, Davidoff, Amy J, Gross, Cary P, Neparidze, Natalia, Miksad, Rebecca A, Calip, Gregory S, Hearn, Caleb M, Ferrell, Will, Shulman, Lawrence N, Mamtani, Ronac, Hubbard, Rebecca A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002283/ https://www.ncbi.nlm.nih.gov/pubmed/34893865 http://dx.doi.org/10.1093/jnci/djab225

Ejemplares similares

Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation
por: Vader, Daniel T., et al.
Publicado: (2023)

Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality
por: Vader, Daniel T, et al.
Publicado: (2022)

The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021
por: Goyal, Gaurav, et al.
Publicado: (2023)

Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic Among Patients with Hematologic Malignancies in the United States
por: Neparidze, Natalia, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States
por: Goyal, Gaurav, et al.
Publicado: (2021)

Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval
por: Parikh, Ravi B., et al.
Publicado: (2023)

Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
por: Mamtani, Ronac, et al.
Publicado: (2023)

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020)

Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review
por: Ioffe, Dina, et al.
Publicado: (2021)

Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival
por: Boursi, Ben, et al.
Publicado: (2023)

Telemedicine use among patients with metastatic breast cancer during the COVID‐19 pandemic: Differences by race, age, and region
por: Calip, Gregory S., et al.
Publicado: (2022)

Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality
por: Miksad, Rebecca A., et al.
Publicado: (2017)

Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone
por: Marar, Mallika, et al.
Publicado: (2022)

Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022
por: Guadamuz, Jenny S, et al.
Publicado: (2023)

Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors
por: Bange, Erin M., et al.
Publicado: (2022)

Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real‐World Practice
por: Parikh, Ravi B., et al.
Publicado: (2019)

Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period
por: Neparidze, Natalia, et al.
Publicado: (2021)

Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period
por: Neparidze, Natalia, et al.
Publicado: (2022)

Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine
por: Miksad, Rebecca A., et al.
Publicado: (2019)

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations
por: Hannan, Zain, et al.
Publicado: (2021)

Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer
por: Sun, Lova, et al.
Publicado: (2021)

Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non–Small Cell Lung Cancer
por: Leapman, Michael S., et al.
Publicado: (2020)

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2022)

Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
por: Narayan, Vivek, et al.
Publicado: (2016)

Long-term Survival After Treating Cardiac Metastasis With Radiation and Immune Therapy: A Case Report
por: Arscott, W. Tristram, et al.
Publicado: (2018)

The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013–2016 from the ClinicalTrials.gov Website
por: Ghatalia, Pooja, et al.
Publicado: (2017)

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
por: Parikh, Ravi B., et al.
Publicado: (2020)

Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study
por: Gotschall, Jeromy W., et al.
Publicado: (2022)

Resolution of a Debilitating Paraneoplastic Parkinson-like Neurological Syndrome Following Tyrosine Inhibitor Therapy and Consolidative Nephrectomy in a Patient with Advanced Clear Cell Renal Cell Carcinoma
por: Ali, Naveed, et al.
Publicado: (2017)

Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer
por: Winer, Arthur, et al.
Publicado: (2021)

Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study
por: Mamtani, Ronac, et al.
Publicado: (2016)

Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K., et al.
Publicado: (2022)

Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma
por: Doshi, Gurjyot K., et al.
Publicado: (2023)

Approved checkpoint inhibitors in bladder cancer: which drug should be used when?
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Role of perioperative immunotherapy in localized renal cell carcinoma
por: Kaur, Jasmeet, et al.
Publicado: (2023)

Public Insurance Eligibility and Enrollment for Special Health Care Needs Children
por: Davidoff, Amy J., et al.
Publicado: (2004)

Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma
por: Roose, James, et al.
Publicado: (2022)

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
por: Arisi, Maria F., et al.
Publicado: (2022)

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study
por: Miksad, Rebecca A., et al.
Publicado: (2019)

Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
por: Mamtani, Ronac, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r8db95ilvedree5v82a10s3apt